| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,077 | 71,478,823 | 0.68% | -0.27% | -3.40% | -4.14% | -2.49% | 23.35% |
| Healthcare | HEALTHCARE | Sector | 1,141 | 6,864,215 | 0.86% | 1.30% | -4.50% | -4.17% | 3.50% | 13.53% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 589 | 3,821,332 | 1.08% | 2.76% | -2.07% | 4.72% | 17.30% | 39.35% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 281 | 1,485,360 | 2.46% | 3.43% | -2.56% | -4.68% | 12.95% | 30.89% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 24 | 27,558 | 0.75% | 5.16% | 8.82% | -5.45% | 28.64% | 99.50% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | MDGL:USAMDGL:USA | Stock | 1 | 12,155 | 1.22% | 14.70% | 24.42% | -9.02% | 17.97% | 63.54% |
| Spyre Therapeutics, Inc. | SYRE:USASYRE:USA | Stock | 1 | 3,790 | -3.05% | 7.05% | 22.04% | 49.27% | 197.08% | 219.71% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 24 | 27,558 | 0.75% | 5.16% | 8.82% | -5.45% | 28.64% | 99.50% |
| Mirum Pharmaceuticals, Inc. | MIRM:USAMIRM:USA | Stock | 1 | 5,666 | 2.42% | 4.94% | 7.77% | 19.79% | 29.62% | 114.85% |
| Ironwood Pharmaceuticals, Inc. | IRWD:USAIRWD:USA | Stock | 1 | 636 | 11.11% | 22.26% | 7.14% | 15.73% | 167.12% | 176.60% |
| Phathom Pharmaceuticals, Inc. | PHAT:USAPHAT:USA | Stock | 1 | 872 | 0.27% | 6.40% | 0.81% | -32.85% | -9.36% | 117.58% |
| Ardelyx, Inc. | ARDX:USAARDX:USA | Stock | 1 | 1,485 | 2.00% | 8.33% | -1.77% | 4.80% | 13.99% | 27.56% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,001 | 95,947,662 | 0.75% | -0.24% | -3.42% | -3.65% | -1.42% | 18.14% |
| Wave Life Sciences Ltd. | WVE:USAWVE:USA | Stock | 1 | 1,250 | -5.79% | -44.47% | -49.18% | -59.82% | -2.84% | -11.76% |
* Colors indicate performance relative to the benchmark.